Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Surrozen, Inc./DE

Surrozen, Inc./DE

Stage unknownSouth San Francisco, CABiotechnology
Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Mar 26, 2025
    Form D equity offering · $76.4M (form d sold) · 29 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Surrozen, Inc./DE filed Form D: $76,402,277 sold of $174,999,955, Biotechnology”
  2. Apr 4, 2024
    Form D equity offering · $193M (form d sold) · 18 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Surrozen, Inc./DE filed Form D: $193,015,962 sold of $193,015,962, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
3 officers, 8 directors
Timeline
2
  1. Apr 8, 2025
    Surrozen, Inc./DE filed Form D: $76,402,277 sold of $174,999,955, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Apr 19, 2024
    Surrozen, Inc./DE filed Form D: $193,015,962 sold of $193,015,962, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
30 observations
Every observation on this company